Maternal morbidity and mortality among patients with cancer at time of delivery.

ABSTRACT:

Background

Individuals with cancer during pregnancy are a medically complex patient population that is anticipated to grow. A better understanding of this population and patterns of risk at time of delivery would offer an opportunity for providers to mitigate maternal morbidity.

Objective

This study aimed to estimate the prevalence in the United States of concurrent cancer diagnoses at time of delivery by cancer type and associated maternal morbidity and mortality.

Study design

Using the National Inpatient Sample, we identified delivery-associated hospitalizations between 2007 and 2018. Concurrent cancer diagnoses were classified using the Clinical Classifications Software. Main outcomes included severe maternal morbidity, as defined by the Centers for Disease Control

SUBMITTER: Sundermann AC 

PROVIDER: S-EPMC10593119 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature